Medical Condition

preeclampsia

Total Trials

12

Recruiting Now

12

Trial Phases

EARLY_Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for preeclampsia sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — preeclampsia Clinical Trials

How many clinical trials are currently recruiting for preeclampsia?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for preeclampsia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for preeclampsia?

preeclampsia research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a preeclampsia clinical trial?

Eligibility criteria for preeclampsia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Enrollment

9,132 pts

Location

Belgium, Colombia, C...

Sponsor

Fundació Institut de Recerca d...

View Trial →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology

preeclampsia

Frequently Asked Questions — preeclampsia Clinical Trials

Recruiting Clinical Trials

Predictors of Aspirin Failure in Preeclampsia Prevention

Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes

Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders

NOPE37: Angiogenic Factors for Managing Term Preeclampsia

Accuracy of Venous Excess Ultrasound Score at Hospital Admission to Predict Acute Kidney Injury

Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications

A Novel Multiomic AI Approach for Early Preeclampsia Prediction in Pregnancy

Dietary Salicylates and Preeclampsia

Excess Base Comparison Between Pregnant Subjects With Severe Preeclampsia vs. Normotensive Pregnant Women

EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE)

Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia

sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.